Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation ExpenseLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Intelligent Bio Solutions (INBS) Receivables - Other (2020 - 2025)

Intelligent Bio Solutions has reported Receivables - Other over the past 5 years, most recently at $525332.0 for Q2 2024.

  • For Q2 2024, Receivables - Other rose 5.33% year-over-year to $525332.0; the TTM value through Jun 2024 reached $525332.0, up 5.33%, while the annual FY2024 figure was $525332.0, 5.33% up from the prior year.
  • Receivables - Other for Q2 2024 was $525332.0 at Intelligent Bio Solutions, up from $332471.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $1.0 million in Q2 2021 and troughed at $7050.0 in Q3 2022.
  • A 5-year average of $336961.9 and a median of $289167.0 in 2023 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: soared 8386.06% in 2021 and later plummeted 99.28% in 2022.
  • Year by year, Receivables - Other stood at $12084.0 in 2020, then skyrocketed by 133.01% to $28157.0 in 2021, then skyrocketed by 124.39% to $63182.0 in 2022, then surged by 357.67% to $289167.0 in 2023, then skyrocketed by 81.67% to $525332.0 in 2024.
  • Business Quant data shows Receivables - Other for INBS at $525332.0 in Q2 2024, $332471.0 in Q1 2024, and $289167.0 in Q4 2023.